title: CREG promotes the proliferation of human umbilical vein endothelial cells through the ERK/cyclin E signaling pathway.
abstract: Cellular repressor of E1A-stimulated genes (CREG) is a recently discovered secreted glycoprotein involved in homeostatic modulation. We previously reported that CREG is abundantly expressed in the adult vascular endothelium and dramatically downregulated in atherosclerotic lesions. In addition, CREG participates in the regulation of apoptosis, inflammation and wound healing of vascular endothelial cells. In the present study, we attempted to investigate the effect of CREG on the proliferation of vascular endothelial cells and to decipher the underlying molecular mechanisms. Overexpression of CREG in human umbilical vein endothelial cells (HUVEC) was obtained by infection with adenovirus carrying CREG. HUVEC proliferation was investigated by flow cytometry and 5-bromo-2'-deoxy-uridine (BrdU) incorporation assays. The expressions of cyclins, cyclin-dependent kinases and signaling molecules were also examined. In CREG-overexpressing cells, we observed a marked increase in the proportion of the S and G2 population and a decrease in the G0/G1 phase population. The number of BrdU positively-stained cells also increased, obviously. Furthermore, silencing of CREG expression by specific short hairpin RNA effectively inhibited the proliferation of human umbilical vein endothelial cells (HUVEC). CREG overexpression induced the expression of cyclin E in both protein and mRNA levels to regulate cell cycle progression. Further investigation using inhibitor blocking analysis identified that ERK activation mediated the CREG modulation of the proliferation and cyclin E expression in HUVEC. In addition, blocking vascular endothelial growth factor (VEGF) in CREG-overexpressed HUVEC and supplementation of VEGF in CREG knocked-down HUVEC identified that the pro-proliferative effect of CREG was partially mediated by VEGF-induced ERK/cyclin E activation. These results suggest a novel role of CREG to promote HUVEC proliferation through the ERK/cyclin E signaling pathway.
authors.affiliation: Graduate School of Third Military Medical University, Chongqing 400038, China. hanyaling@gmail.com.
authors.forename: Jie
authors.initials: J
authors.lastname: Tao
authors.forename: Chenghui
authors.initials: C
authors.lastname: Yan
authors.forename: Xiaoxiang
authors.initials: X
authors.lastname: Tian
authors.forename: Shaowei
authors.initials: S
authors.lastname: Liu
authors.forename: Yang
authors.initials: Y
authors.lastname: Li
authors.forename: Jian
authors.initials: J
authors.lastname: Zhang
authors.forename: Mingyu
authors.initials: M
authors.lastname: Sun
authors.forename: Xinliang
authors.initials: X
authors.lastname: Ma
authors.forename: Yaling
authors.initials: Y
authors.lastname: Han
mesh_terms: D015153:Blotting, Western; D002478:Cells, Cultured; D019927:Cyclin E / Q000235:genetics / Q000378:metabolism*; D061307:Human Umbilical Vein Endothelial Cells / Q000166:cytology* / Q000378:metabolism*; D006801:Humans; D020935:MAP Kinase Signaling System / Q000235:genetics / Q000502:physiology*; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction
chemical_list: C114068:CREG1 protein, human; D019927:Cyclin E; D012097:Repressor Proteins
references.citation: PLoS One. 2011;6(7):e21938
references.pmid: 21765927
references.citation: Can J Physiol Pharmacol. 2012 Jun;90(6):713-38
references.pmid: 22625870
references.citation: Dev Biol. 2009 Oct 15;334(2):383-94
references.pmid: 19665013
references.citation: Nat Rev Cardiol. 2012 May 22;9(8):439-53
references.pmid: 22614618
references.citation: Biochem Biophys Res Commun. 2011 Mar 25;406(4):601-7
references.pmid: 21354106
references.citation: Atherosclerosis. 2011 Oct;218(2):543-51
references.pmid: 21872252
references.citation: J Appl Physiol (1985). 2001 Sep;91(3):1431-7
references.pmid: 11509545
references.citation: Cardiovasc Res. 2009 May 1;82(2):261-71
references.pmid: 19038971
references.citation: Am J Cardiol. 2007 Sep 15;100(6):919-23
references.pmid: 17826370
references.citation: Dig Dis Sci. 2011 Jun;56(6):1645-55
references.pmid: 21132365
references.citation: Cardiovasc Res. 2008 Jun 1;78(3):597-604
references.pmid: 18267954
references.citation: Cell Tissue Res. 2009 Jan;335(1):67-73
references.pmid: 18682987
references.citation: EMBO J. 1996 Aug 15;15(16):4182-93
references.pmid: 8861947
references.citation: Mol Cancer. 2011 Jul 13;10:84
references.pmid: 21752283
references.citation: Genes Dev. 1999 Jun 15;13(12):1501-12
references.pmid: 10385618
references.citation: J Mol Cell Cardiol. 2010 Jun;48(6):1225-35
references.pmid: 20060003
references.citation: J Hypertens. 2004 Aug;22(8):1579-87
references.pmid: 15257182
references.citation: Mol Cell Biol. 1998 Sep;18(9):5032-41
references.pmid: 9710587
references.citation: Cell Div. 2007 Feb 12;2:6
references.pmid: 17295909
references.citation: Oncogene. 2003 Aug 21;22(35):5436-45
references.pmid: 12934103
references.citation: Exp Cell Res. 2011 Dec 10;317(20):2904-13
references.pmid: 21939655
references.citation: Genomics. 2002 Nov;80(5):456-60
references.pmid: 12408961
references.citation: PLoS One. 2013;8(4):e60735
references.pmid: 23573278
references.citation: Ann Med. 2010 Apr;42(3):171-7
references.pmid: 20384433
references.citation: Dev Cell. 2008 Feb;14(2):159-69
references.pmid: 18267085
references.citation: Oncogene. 2000 Apr 20;19(17):2120-8
references.pmid: 10815803
references.citation: Exp Cell Res. 2008 Oct 1;314(16):3036-47
references.pmid: 18621046
references.citation: Genes Dev. 2004 Nov 15;18(22):2699-711
references.pmid: 15545627
references.citation: Blood. 2010 Oct 21;116(16):3108-17
references.pmid: 20664058